About this Journal Submit a Manuscript Table of Contents 
Journal of Lipids
Volume 2011 (2011), Article ID 565316, 15 pages
doi:10.1155/2011/565316
Review Article

Apoptotic Sphingolipid Ceramide in Cancer Therapy

Wei-Ching Huang,1,2 Chia-Ling Chen,3 Yee-Shin Lin,1,3 and Chiou-Feng Lin1,2,3

1Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan 701, Taiwan
2Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan 701, Taiwan
3Department of Microbiology and Immunology, College of Medicine, National Cheng Kung University, Tainan 701, Taiwan

Received 24 August 2010; Accepted 26 October 2010

Academic Editor: Xian-Cheng Jiang

Copyright © 2011 Wei-Ching Huang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Z. Jin and W. S. El-Deiry, “Overview of cell death signaling pathways,” Cancer Biology and Therapy, vol. 4, no. 2, pp. 139–163, 2005. View at Scopus
  2. Y. A. Hannun and L. M. Obeid, “Principles of bioactive lipid signalling: lessons from sphingolipids,” Nature Reviews Molecular Cell Biology, vol. 9, no. 2, pp. 139–150, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. S. Lahiri and A. H. Futerman, “The metabolism and function of sphingolipids and glycosphingolipids,” Cellular and Molecular Life Sciences, vol. 64, no. 17, pp. 2270–2284, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. H. Fyrst and J. D. Saba, “An update on sphingosine-1-phosphate and other sphingolipid mediators,” Nature Chemical Biology, vol. 6, no. 7, pp. 489–497, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. N. Bartke and Y. A. Hannun, “Bioactive sphingolipids: metabolism and function,” Journal of lipid research, vol. 50, pp. S91–S96, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. M. J. Smyth, L. M. Obeid, and Y. A. Hannun, “Ceramide: a novel lipid mediator of apoptosis,” Advances in Pharmacology, vol. 41, pp. 133–154, 1997. View at Scopus
  7. A. Morales, H. Lee, F. M. Goñi, R. Kolesnick, and J. C. Fernandez-Checa, “Sphingolipids and cell death,” Apoptosis, vol. 12, no. 5, pp. 923–939, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. B. Ogretmen and Y. A. Hannun, “Biologically active sphingolipids in cancer pathogenesis and treatment,” Nature Reviews Cancer, vol. 4, no. 8, pp. 604–616, 2004. View at Scopus
  9. S. A. Saddoughi, P. Song, and B. Ogretmen, “Roles of bioactive sphingolipids in cancer biology and therapeutics,” Sub-Cellular Biochemistry, vol. 49, pp. 413–440, 2008. View at Scopus
  10. A. Huwiler and U. Zangemeister-Wittke, “Targeting the conversion of ceramide to sphingosine 1-phosphate as a novel strategy for cancer therapy,” Critical Reviews in Oncology/Hematology, vol. 63, no. 2, pp. 150–159, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. C. P. Reynolds, B. J. Maurer, and R. N. Kolesnick, “Ceramide synthesis and metabolism as a target for cancer therapy,” Cancer Letters, vol. 206, no. 2, pp. 169–180, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. B. J. Pettus, C. E. Chalfant, and Y. A. Hannun, “Ceramide in apoptosis: an overview and current perspectives,” Biochimica et Biophysica Acta, vol. 1585, no. 2-3, pp. 114–125, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. A. Hannun and C. Luberto, “Ceramide in the eukaryotic stress response,” Trends in Cell Biology, vol. 10, no. 2, pp. 73–80, 2000. View at Publisher · View at Google Scholar · View at Scopus
  14. C. F. Lin, C. L. Chen, and Y. S. Lin, “Ceramide in apoptotic signaling and anticancer therapy,” Current Medicinal Chemistry, vol. 13, no. 14, pp. 1609–1616, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Dhein, H. Walczak, C. Baumler, K. M. Debatin, and P. H. Krammer, “Autocrine T-cell suicide mediated by APO-1/(Fas/CD95),” Nature, vol. 373, no. 6513, pp. 438–441, 1995. View at Scopus
  16. L. A. Tartaglia, M. Rothe, Y. F. Hu, and D. V. Goeddel, “Tumor necrosis factor's cytotoxic activity is signaled by the p55 TNF receptor,” Cell, vol. 73, no. 2, pp. 213–216, 1993. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Kitson, T. Raven, and T. Raven, “A death-domain-containing receptor that mediates apoptosis,” Nature, vol. 384, no. 6607, pp. 372–375, 1996. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. G. Pan, K. O'Rourke, A. M. Chinnaiyan, R. Gentz, R. Ebner, J. Ni, and V. M. Dixit, “The receptor for the cytotoxic ligand TRAIL,” Science, vol. 276, no. 5309, pp. 111–113, 1997. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Ashkenazi and V. M. Dixit, “Death receptors: signaling and modulation,” Science, vol. 281, no. 5381, pp. 1305–1308, 1998. View at Scopus
  20. D. R. Green and J. C. Reed, “Mitochondria and apoptosis,” Science, vol. 281, no. 5381, pp. 1309–1312, 1998. View at Scopus
  21. G. Kroemer and J. C. Reed, “Mitochondrial control of cell death,” Nature Medicine, vol. 6, no. 5, pp. 513–519, 2000. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. J. C. Reed, “Bcl-2 family proteins,” Oncogene, vol. 17, no. 25, pp. 3225–3236, 1998. View at Scopus
  23. XU. Luo, I. Budihardjo, H. Zou, C. Slaughter, and X. Wang, “Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors,” Cell, vol. 94, no. 4, pp. 481–490, 1998. View at Scopus
  24. N. Zamzami, C. E. Hamel, and C. E. Hamel, “Bid acts on the permeability transition pore complex to induce apoptosis,” Oncogene, vol. 19, no. 54, pp. 6342–6350, 2000. View at Publisher · View at Google Scholar · View at Scopus
  25. C. Xu, B. Bailly-Maitre, and J. C. Reed, “Endoplasmic reticulum stress: cell life and death decisions,” Journal of Clinical Investigation, vol. 115, no. 10, pp. 2656–2664, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. J. Wu and R. J. Kaufman, “From acute ER stress to physiological roles of the unfolded protein response,” Cell Death and Differentiation, vol. 13, no. 3, pp. 374–384, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  27. D. G. Breckenridge, M. Germain, J. P. Mathai, M. Nguyen, and G. C. Shore, “Regulation of apoptosis by endoplasmic reticulum pathways,” Oncogene, vol. 22, no. 53, pp. 8608–8618, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  28. J. Matsukawa, A. Matsuzawa, K. Takeda, and H. Ichijo, “The ASK1-MAP kinase cascades in mammalian stress response,” Journal of Biochemistry, vol. 136, no. 3, pp. 261–265, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  29. H. Nishitoh, A. Matsuzawa, and A. Matsuzawa, “ASK1 is essential for endoplasmic reticulum stress-induced neuronal cell death triggered by expanded polyglutamine repeats,” Genes and Development, vol. 16, no. 11, pp. 1345–1355, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  30. M. K. Dahmer, “Caspases-2, -3, and -7 are involved in thapsigargin-induced apoptosis of SH-SY5Y neuroblastoma cells,” Journal of Neuroscience Research, vol. 80, no. 4, pp. 576–583, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  31. H. H. Cheung, N. Lynn Kelly, P. Liston, and R. G. Korneluk, “Involvement of caspase-2 and caspase-9 in endoplasmic reticulum stress-induced apoptosis: a role for the IAPs,” Experimental Cell Research, vol. 312, no. 12, pp. 2347–2357, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  32. J. P. Upton, K. Austgen, and K. Austgen, “Caspase-2 cleavage of BID is a critical apoptotic signal downstream of endoplasmic reticulum stress,” Molecular and Cellular Biology, vol. 28, no. 12, pp. 3943–3951, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  33. K. D. McCullough, J. L. Martindale, L. O. Klotz, T. Y. Aw, and N. J. Holbrook, “Gadd153 sensitizes cells to endoplasmic reticulum stress by down-regulating Bc12 and perturbing the cellular redox state,” Molecular and Cellular Biology, vol. 21, no. 4, pp. 1249–1259, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  34. Y. Tan, N. Dourdin, C. Wu, T. de Veyra, J. S. Elce, and P. A. Greer, “Ubiquitous calpains promote caspase-12 and JNK activation during endoplasmic reticulum stress-induced apoptosis,” Journal of Biological Chemistry, vol. 281, no. 23, pp. 16016–16024, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  35. K. F. Ferri and G. Kroemer, “Organelle-specific initiation of cell death pathways,” Nature Cell Biology, vol. 3, no. 11, pp. E255–E263, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  36. M. E. Guicciardi, M. Leist, and G. J. Gores, “Lysosomes in cell death,” Oncogene, vol. 23, no. 16, pp. 2881–2890, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  37. G. Kroemer and M. Jäättelä, “Lysosomes and autophagy in cell death control,” Nature Reviews Cancer, vol. 5, no. 11, pp. 886–897, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  38. C. E. Chwieralski, T. Welte, and F. Bühling, “Cathepsin-regulated apoptosis,” Apoptosis, vol. 11, no. 2, pp. 143–149, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  39. N. Marchesini and Y. A. Hannun, “Acid and neutral sphingomyelinases: roles and mechanisms of regulation,” Biochemistry and Cell Biology, vol. 82, no. 1, pp. 27–44, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  40. R. J. Perry and N. D. Ridgway, “Molecular mechanisms and regulation of ceramide transport,” Biochimica et Biophysica Acta, vol. 1734, no. 3, pp. 220–234, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  41. G. F. Nixon, “Sphingolipids in inflammation: pathological implications and potential therapeutic targets,” British Journal of Pharmacology, vol. 158, no. 4, pp. 982–993, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  42. S. Schiffmann, J. Sandner, and J. Sandner, “The selective COX-2 inhibitor celecoxib modulates sphingolipid synthesis,” Journal of Lipid Research, vol. 50, no. 1, pp. 32–40, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  43. T. Ariga, W. D. Jarvis, and R. K. Yu, “Role of sphingolipid-mediated cell death in neurodegenerative diseases,” Journal of Lipid Research, vol. 39, no. 1, pp. 1–16, 1998. View at Scopus
  44. C. Grullich, M. C. Sullards, Z. Fuks, A. H. Merrill Jr., and R. Kolesnick, “CD95(Fas/APO-1) signals ceramide generation independent of the effector stage of apoptosis,” Journal of Biological Chemistry, vol. 275, no. 12, pp. 8650–8656, 2000. View at Publisher · View at Google Scholar · View at Scopus
  45. L. M. Obeid, C. M. Linardic, L. A. Karolak, and Y. A. Hannun, “Programmed cell death induced by ceramide,” Science, vol. 259, no. 5102, pp. 1769–1771, 1993. View at Scopus
  46. K. Hofmann and V. M. Dixit, “Ceramide in apoptosis—does it really matter?” Trends in Biochemical Sciences, vol. 23, no. 10, pp. 374–377, 1998. View at Publisher · View at Google Scholar · View at Scopus
  47. R. Kolesnick and Y. A. Hannun, “Ceramide and apoptosis,” Trends in Biochemical Sciences, vol. 24, pp. 224–227, 1999.
  48. J. D. Watts, R. Aebersold, A. J. Polverino, S. D. Patterson, and M. Gu, “Ceramide second messengers and ceramide assays,” Trends in Biochemical Sciences, vol. 24, no. 6, article 228, 1999.
  49. R. N. Kolesnick, A. Haimovitz-Friedman, and Z. Fuks, “The sphingomyelin signal transduction pathway mediates apoptosis for tumor necrosis factor, Fas, and ionizing radiation,” Biochemistry and Cell Biology, vol. 72, no. 11-12, pp. 471–474, 1994. View at Scopus
  50. R. Schwandner, K. Wiegmann, K. Bernardo, D. Kreder, and M. Krönke, “TNF receptor death domain-associated proteins TRADD and FADD signal activation of acid sphingomyelinase,” Journal of Biological Chemistry, vol. 273, no. 10, pp. 5916–5922, 1998. View at Publisher · View at Google Scholar · View at Scopus
  51. T. Lin, L. Genestier, and L. Genestier, “Role of acidic sphingomyelinase in Fas/CD95-mediated cell death,” Journal of Biological Chemistry, vol. 275, no. 12, pp. 8657–8663, 2000. View at Publisher · View at Google Scholar · View at Scopus
  52. C. García-Ruiz, A. Colell, M. Mari, A. Morales, M. Calvo, C. Enrich, and J. C. Fernández-Checa, “Defective TNF-α-mediated hepatocellular apoptosis and liver damage in acidic sphingomyelinase knockout mice,” Journal of Clinical Investigation, vol. 111, no. 2, pp. 197–208, 2003. View at Publisher · View at Google Scholar · View at Scopus
  53. B. Ségui, O. Cuvillier, and O. Cuvillier, “Involvement of FAN in TNF-induced apoptosis,” Journal of Clinical Investigation, vol. 108, no. 1, pp. 143–151, 2001. View at Publisher · View at Google Scholar · View at Scopus
  54. R. N. Kolesnick, F. M. Goñi, and A. Alonso, “Compartmentalization of ceramide signaling: physical foundations and biological effects,” Journal of Cellular Physiology, vol. 184, no. 3, pp. 285–300, 2000. View at Publisher · View at Google Scholar · View at Scopus
  55. A. Bielawska, H. M. Crane, D. Liotta, L. M. Obeid, and Y. A. Hannun, “Selectivity of ceramide-mediated biology. Lack of activity of erythro-dihydroceramide,” Journal of Biological Chemistry, vol. 268, no. 35, pp. 26226–26232, 1993. View at Scopus
  56. M. J. Smyth, D. K. Perry, J. Zhang, G. G. Poirier, Y. A. Hannun, and L. M. Obeid, “prICE: a downstream target for ceramide-induced apoptosis and for the inhibitory action of Bcl-2,” Biochemical Journal, vol. 316, no. 1, pp. 25–28, 1996. View at Scopus
  57. S. J. Martin, D. D. Newmeyer, and D. D. Newmeyer, “Cell-free reconstitution of Fas-, UV radiation- and ceramide-induced apoptosis,” EMBO Journal, vol. 14, no. 21, pp. 5191–5200, 1995. View at Scopus
  58. Y. A. Hannun and C. M. Linardic, “Sphingolipid breakdown products: anti-proliferative and tumor-suppressor lipids,” Biochimica et Biophysica Acta, vol. 1154, no. 3-4, pp. 223–236, 1993. View at Scopus
  59. A. F. Nica, C. T. Chun, and C. T. Chun, “Ceramide promotes apoptosis in chronic myelogenous leukemia-derived K562 cells by a mechanism involving caspase-8 and JNK,” Cell Cycle, vol. 7, no. 21, pp. 3362–3370, 2008. View at Scopus
  60. V. Maguer-Satta, S. Burl, and S. Burl, “BCR-ABL accelerates C2-ceramide-induced apoptosis,” Oncogene, vol. 16, no. 2, pp. 237–248, 1998. View at Scopus
  61. X. Liu, L. Ryland, J. Yang, et al., “Targeting of survivin by nanoliposomal ceramide induces complete remission in a rat model of NK-LGL leukemia,” Blood, vol. 16, no. 20, pp. 4192–4201, 2010.
  62. B. Ogretmen, B. J. Pettus, and B. J. Pettus, “Biochemical mechanisms of the generation of endogenous long chain ceramide in response to exogenous short chain ceramide in the A549 human lung adenocarcinoma cell line. Role for endogenous ceramide in mediating the action of exogenous ceramide,” Journal of Biological Chemistry, vol. 277, no. 15, pp. 12960–12969, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  63. S. Karahatay, K. Thomas, and K. Thomas, “Clinical relevance of ceramide metabolism in the pathogenesis of human head and neck squamous cell carcinoma (HNSCC): attenuation of C-ceramide in HNSCC tumors correlates with lymphovascular invasion and nodal metastasis,” Cancer Letters, vol. 256, no. 1, pp. 101–111, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  64. S. Koybasi, C. E. Senkal, and C. E. Senkal, “Defects in cell growth regulation by C-ceramide and longevity assurance gene 1 in human head and neck squamous cell carcinomas,” Journal of Biological Chemistry, vol. 279, no. 43, pp. 44311–44319, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  65. C. E. Senkal, S. Ponnusamy, and S. Ponnusamy, “Role of human longevity assurance gene 1 and C-ceramide in chemotherapy-induced cell death in human head and neck squamous cell carcinomas,” Molecular Cancer Therapeutics, vol. 6, no. 2, pp. 712–722, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  66. C. E. Senkal, S. Ponnusamy, J. Bielawski, Y. A. Hannun, and B. Ogretmen, “Antiapoptotic roles of ceramide-synthase-6-generated C- ceramide via selective regulation of the ATF6/ CHOP arm of ER-stress-response pathways,” FASEB Journal, vol. 24, no. 1, pp. 296–308, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  67. A. Srinivasan, L. M. Foster, M. P. Testa, T. Örd, R. W. Keane, D. E. Bredesen, and C. Kayalar, “Bcl-2 expression in neural cells blocks activation of ICE/CED-3 family proteases during apoptosis,” Journal of Neuroscience, vol. 16, no. 18, pp. 5654–5660, 1996. View at Scopus
  68. C. García-Ruiz, A. Colell, M. Marí, A. Morales, and J. C. Fernández-Checa, “Direct effect of ceramide on the mitochondrial electron transport chain leads to generation of reactive oxygen species: role of mitochondrial glutathione,” Journal of Biological Chemistry, vol. 272, no. 17, pp. 11369–11377, 1997. View at Publisher · View at Google Scholar · View at Scopus
  69. T. I. Gudz, K. Y. Tserng, and C. L. Hoppel, “Direct inhibition of mitochondrial respiratory chain complex III by cell-permeable ceramide,” Journal of Biological Chemistry, vol. 272, no. 39, pp. 24154–24158, 1997. View at Publisher · View at Google Scholar · View at Scopus
  70. A. Quillet-Mary, J. P. Jaffrézou, V. Mansat, C. Bordier, J. Naval, and G. Laurent, “Implication of mitochondrial hydrogen peroxide generation in ceramide-induced apoptosis,” Journal of Biological Chemistry, vol. 272, no. 34, pp. 21388–21395, 1997. View at Publisher · View at Google Scholar · View at Scopus
  71. L. J. Siskind, R. N. Kolesnick, and M. Colombini, “Ceramide channels increase the permeability of the mitochondrial outer membrane to small proteins,” Journal of Biological Chemistry, vol. 277, no. 30, pp. 26796–26803, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  72. L. J. Siskind, R. N. Kolesnick, and M. Colombini, “Ceramide forms channels in mitochondrial outer membranes at physiologically relevant concentrations,” Mitochondrion, vol. 6, no. 3, pp. 118–125, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  73. H. Birbes, C. Luberto, Y. T. Hsu, S. El Bawab, Y. A. Hannun, and L. M. Obeid, “A mitochondrial pool of sphingomyelin is involved in TNFα-induced Bax translocation to mitochondria,” Biochemical Journal, vol. 386, no. 3, pp. 445–451, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  74. S. El Bawab, P. Roddy, T. Qian, A. Bielawska, J. J. Lemasters, and Y. A. Hannun, “Molecular cloning and characterization of a human mitochondrial ceramidase,” Journal of Biological Chemistry, vol. 275, no. 28, pp. 21508–21513, 2000. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  75. C. Bionda, J. Portoukalian, D. Schmitt, C. Rodriguez-Lafrasse, and D. Ardail, “Subcellular compartmentalization of ceramide metabolism: MAM (mitochondria-associated membrane) and/or mitochondria?” Biochemical Journal, vol. 382, no. 2, pp. 527–533, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  76. H. Birbes, S. El Bawab, Y. A. Hannun, and L. M. Obeid, “Selective hydrolysis of a mitochondrial pool of sphingomyelin induces apoptosis,” FASEB Journal, vol. 15, no. 14, pp. 2669–2679, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  77. C. F. Lin, C. L. Chen, and C. L. Chen, “Bcl-2 rescues ceramide- and etoposide-induced mitochondrial apoptosis through blockage of caspase-2 activation,” Journal of Biological Chemistry, vol. 280, no. 25, pp. 23758–23765, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  78. M. Fillet, M. Bentires-Alj, and M. Bentires-Alj, “Mechanisms involved in exogenous C2- and C6-ceramide-induced cancer cell toxicity,” Biochemical Pharmacology, vol. 65, no. 10, pp. 1633–1642, 2003. View at Publisher · View at Google Scholar · View at Scopus
  79. C. F. Lin, C. L. Chen, and C. L. Chen, “Sequential caspase-2 and caspase-8 activation upstream of mitochondria during ceramide- and etoposide-induced apoptosis,” Journal of Biological Chemistry, vol. 279, no. 39, pp. 40755–40761, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  80. C. F. Lin, C. L. Chen, C. W. Chiang, M. S. Jan, W. C. Huang, and Y. S. Lin, “GSK-3β acts downstream of PP2A and the PI 3-kinase-Akt pathway, and upstream of caspase-2 in ceramide-induced mitochondrial apoptosis,” Journal of Cell Science, vol. 120, no. 16, pp. 2935–2943, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  81. K. Hanada, K. Kumagai, S. Yasuda, Y. Miura, M. Kawano, M. Fukasawa, and M. Nishijima, “Molecular machinery for non-vesicular trafficking of ceramide,” Nature, vol. 426, no. 6968, pp. 803–809, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  82. S. D. Spassieva, T. D. Mullen, D. M. Townsend, and L. M. Obeid, “Disruption of ceramide synthesis by CerS2 down-regulation leads to autophagy and the unfolded protein response,” Biochemical Journal, vol. 424, no. 2, pp. 273–283, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  83. A. Carracedo, M. Lorente, and M. Lorente, “The stress-regulated protein p8 mediates cannabinoid-induced apoptosis of tumor cells,” Cancer Cell, vol. 9, no. 4, pp. 301–312, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  84. M. A. Park, G. Zhang, and G. Zhang, “Vorinostat and sorafenib increase ER stress, autophagy and apoptosis via ceramide-dependent CD95 and PERK activation,” Cancer Biology and Therapy, vol. 7, no. 10, pp. 1648–1662, 2008. View at Scopus
  85. C. Swanton, M. Marani, and M. Marani, “Regulators of mitotic arrest and ceramide metabolism are determinants of sensitivity to paclitaxel and other chemotherapeutic drugs,” Cancer Cell, vol. 11, no. 6, pp. 498–512, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  86. R. Kolesnick, D. Altieri, and Z. Fuks, “A CERTain role for ceramide in taxane-induced cell death,” Cancer Cell, vol. 11, no. 6, pp. 473–475, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  87. C. L. Chen, C. F. Lin, W. T. Chang, W. C. Huang, C. F. Teng, and Y. S. Lin, “Ceramide induces p38 MAPK and JNK activation through a mechanism involving a thioredoxin-interacting protein-mediated pathway,” Blood, vol. 111, no. 8, pp. 4365–4374, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  88. M. Verheij, R. Bose, and R. Bose, “Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis,” Nature, vol. 380, no. 6569, pp. 75–79, 1996. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  89. D. L. Eizirik, A. K. Cardozo, and M. Cnop, “The role for endoplasmic reticulum stress in diabetes mellitus,” Endocrine Reviews, vol. 29, no. 1, pp. 42–61, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  90. M. Flamment, H. L. Kammoun, I. Hainault, P. Ferré, and F. Foufelle, “Endoplasmic reticulum stress: a new actor in the development of hepatic steatosis,” Current Opinion in Lipidology, vol. 21, no. 3, pp. 239–246, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  91. I. Tabas, “The role of endoplasmic reticulum stress in the progression of atherosclerosis,” Circulation Research, vol. 107, pp. 839–850, 2010.
  92. S. A. Summers, “Ceramides in insulin resistance and lipotoxicity,” Progress in Lipid Research, vol. 45, no. 1, pp. 42–72, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  93. W. L. Holland, J. T. Brozinick, and J. T. Brozinick, “Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance,” Cell Metabolism, vol. 5, no. 3, pp. 167–179, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  94. M. Shimabukuro, Y. T. Zhou, M. Levi, and R. H. Unger, “Fatty acid-induced β cell apoptosis: a link between obesity and diabetes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 5, pp. 2498–2502, 1998. View at Publisher · View at Google Scholar · View at Scopus
  95. S. Patil, J. Melrose, and C. Chan, “Involvement of astroglial ceramide in palmitic acid-induced Alzheimer-like changes in primary neurons,” European Journal of Neuroscience, vol. 26, no. 8, pp. 2131–2141, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  96. Y. Wei, D. Wang, F. Topczewski, and M. J. Pagliassotti, “Saturated fatty acids induce endoplasmic reticulum stress and apoptosis independently of ceramide in liver cells,” American Journal of Physiology—Endocrinology and Metabolism, vol. 291, no. 2, pp. E275–E281, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  97. M. Heinrich, J. Neumeyer, and J. Neumeyer, “Cathepsin D links TNF-induced acid sphingomyelinase to Bid-mediated caspase-9 and -3 activation,” Cell Death and Differentiation, vol. 11, no. 5, pp. 550–563, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  98. D. de Stefanis, P. Reffo, and P. Reffo, “Increase in ceramide level alters the lysosomal targeting of cathepsin D prior to onset of apoptosis in HT-29 colon cancer cells,” Biological Chemistry, vol. 383, no. 6, pp. 989–999, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  99. C. A. Dumitru, I. E. Sandalcioglu, M. Wagner, M. Weller, and E. Gulbins, “Lysosomal ceramide mediates gemcitabine-induced death of glioma cells,” Journal of Molecular Medicine, vol. 87, no. 11, pp. 1123–1132, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  100. M. Heinrich, M. Wickel, and M. Wickel, “Ceramide as an activator lipid of cathepsin D,” Advances in Experimental Medicine and Biology, vol. 477, pp. 305–315, 2000. View at Scopus
  101. M. Heinrich, M. Wickel, and M. Wickel, “Cathepsin D targeted by acid sphingomyelinase-derived ceramide,” EMBO Journal, vol. 18, no. 19, pp. 5252–5263, 1999. View at Publisher · View at Google Scholar · View at PubMed
  102. A. E. Feldstein, N. W. Werneburg, Z. Li, S. F. Bronk, and G. J. Gores, “Bax inhibition protects against free fatty acid-induced lysosomal permeabilization,” American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 290, no. 6, pp. G1339–G1346, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  103. Y. Y. Liu, T. Y. Han, A. E. Giuliano, and M. C. Cabot, “Expression of glucosylceramide synthase, converting ceramide to glucosylceramide, confers adriamycin resistance in human breast cancer cells,” Journal of Biological Chemistry, vol. 274, no. 2, pp. 1140–1146, 1999. View at Publisher · View at Google Scholar
  104. V. Gouazé, J. Y. Yu, and J. Y. Yu, “Overexpression of glucosylceramide synthase and P-glycoprotein in cancer cells selected for resistance to natural product chemotherapy,” Molecular Cancer Therapeutics, vol. 3, no. 5, pp. 633–639, 2004.
  105. M. Itoh, T. Kitano, and T. Kitano, “Possible role of ceramide as an indicator of chemoresistance: decrease of the ceramide content via activation of glucosylceramide synthase and sphingomyelin synthase in chemoresistant leukemia,” Clinical Cancer Research, vol. 9, no. 1 I, pp. 415–423, 2003.
  106. Y. Y. Liu, T. Y. Han, A. E. Giuliano, N. Hansen, and M. C. Cabot, “Uncoupling ceramide glycosylation by transfection of glucosylceramide synthase antisense reverses adriamycin resistance,” Journal of Biological Chemistry, vol. 275, no. 10, pp. 7138–7143, 2000. View at Publisher · View at Google Scholar
  107. V. Gouazé, Y. Y. Liu, C. S. Prickett, J. Y. Yu, A. E. Giuliano, and M. C. Cabot, “Glucosylceramide synthase blockade down-regulates P-glycoprotein and resensitizes multidrug-resistant breast cancer cells to anticancer drugs,” Cancer Research, vol. 65, no. 9, pp. 3861–3867, 2005. View at Publisher · View at Google Scholar · View at PubMed
  108. G. A. Patwardhan, Q. J. Zhang, and Q. J. Zhang, “A new mixed-backbone oligonucleotide against glucosylceramide synthase sensitizes multidrug-resistant tumors to apoptosis,” PLoS ONE, vol. 4, no. 9, article e6938, 2009. View at Publisher · View at Google Scholar · View at PubMed
  109. Y.-Y. Liu, V. Gupta, and V. Gupta, “Glucosylceramide synthase upregulates MDR1 expression in the regulation of cancer drug resistance through cSrc and β-catenin signaling,” Molecular Cancer, vol. 9, article 145, 2010. View at Publisher · View at Google Scholar · View at PubMed
  110. S. di Bartolomeo and A. Spinedi, “Differential chemosensitizing effect of two glucosylceramide synthase inhibitors in hepatoma cells,” Biochemical and Biophysical Research Communications, vol. 288, no. 1, pp. 269–274, 2001. View at Publisher · View at Google Scholar · View at PubMed
  111. P. Xie, Y. F. Shen, and Y. F. Shen, “Overexpression of glucosylceramide synthase in associated with multidrug resistance of leukemia cells,” Leukemia Research, vol. 32, no. 3, pp. 475–480, 2008. View at Publisher · View at Google Scholar · View at PubMed
  112. A. F. Saad, W. D. Meacham, and W. D. Meacham, “The functional effects of acid ceramidase overexpression in prostate cancer progression and resistance to chemotherapy,” Cancer Biology and Therapy, vol. 6, no. 9, pp. 1455–1460, 2007.
  113. A. Morales, R. París, A. Villanueva, L. Llacuna, C. García-Ruiz, and J. C. Fernández-Checa, “Pharmacological inhibition or small interfering RNA targeting acid ceramidase sensitizes hepatoma cells to chemotherapy and reduces tumor growth in vivo,” Oncogene, vol. 26, no. 6, pp. 905–916, 2007. View at Publisher · View at Google Scholar · View at PubMed
  114. G. Illuzzi, C. Bernacchioni, and C. Bernacchioni, “Sphingosine kinase mediates resistance to the synthetic retinoid N-(4-hydroxyphenyl)retinamide in human ovarian cancer cells,” Journal of Biological Chemistry, vol. 285, no. 24, pp. 18594–18602, 2010. View at Publisher · View at Google Scholar · View at PubMed
  115. E. Bonhoure, D. Pchejetski, N. Aouali, H. Morjani, T. Levade, T. Kohama, and O. Cuvillier, “Overcoming MDR-associated chemoresistance in HL-60 acute myeloid leukemia cells by targeting shingosine kinase-1,” Leukemia, vol. 20, no. 1, pp. 95–102, 2006. View at Publisher · View at Google Scholar · View at PubMed
  116. J. Guillermet-Guibert, L. Davenne, and L. Davenne, “Targeting the sphingolipid metabolism to defeat pancreatic cancer cell resistance to the chemotherapeutic gemcitabine drug,” Molecular Cancer Therapeutics, vol. 8, no. 4, pp. 809–820, 2009. View at Publisher · View at Google Scholar · View at PubMed
  117. S. Sobue, S. Nemoto, and S. Nemoto, “Implications of sphingosine kinase 1 expression level for the cellular sphingolipid rheostat: relevance as a marker for daunorubicin sensitivity of leukemia cells,” International Journal of Hematology, vol. 87, no. 3, pp. 266–275, 2008. View at Publisher · View at Google Scholar · View at PubMed
  118. Y. Akao, Y. Banno, and Y. Banno, “High expression of sphingosine kinase 1 and S1P receptors in chemotherapy-resistant prostate cancer PC3 cells and their camptothecin-induced up-regulation,” Biochemical and Biophysical Research Communications, vol. 342, no. 4, pp. 1284–1290, 2006. View at Publisher · View at Google Scholar · View at PubMed
  119. S. Nemoto, M. Nakamura, and M. Nakamura, “Sphingosine kinase isoforms regulate oxaliplatin sensitivity of human colon cancer cells through ceramide accumulation and Akt activation,” Journal of Biological Chemistry, vol. 284, no. 16, pp. 10422–10432, 2009. View at Publisher · View at Google Scholar · View at PubMed
  120. G. Grammatikos, V. Teichgräber, A. Carpinteiro, T. Trarbach, M. Weller, U. R. Hengge, and E. Gulbins, “Overexpression of acid sphingomyelinase sensitizes glioma cells to chemotherapy,” Antioxidants and Redox Signaling, vol. 9, no. 9, pp. 1449–1456, 2007. View at Publisher · View at Google Scholar · View at PubMed
  121. J. Min, P. P. van Veldhoven, L. Zhang, M. H. Hanigan, H. Alexander, and S. Alexander, “Sphingosine-1-phosphate lyase regulates sensitivity of human cells to select chemotherapy drugs in a p38-dependent manner,” Molecular Cancer Research, vol. 3, no. 5, pp. 287–296, 2005. View at Publisher · View at Google Scholar · View at PubMed
  122. M. M. Gottesman, “Mechanisms of cancer drug resistance,” Annual Review of Medicine, vol. 53, pp. 615–627, 2002. View at Publisher · View at Google Scholar · View at PubMed
  123. P. Giménez-Bonafé, A. Tortosa, and R. Pérez-Tomás, “Overcoming drug resistance by enhancing apoptosis of tumor cells,” Current Cancer Drug Targets, vol. 9, no. 3, pp. 320–340, 2009. View at Publisher · View at Google Scholar
  124. S. G. Lutzker and A. J. Levine, “Apoptosis and cancer chemotherapy,” Cancer Treatment and Research, vol. 87, pp. 345–356, 1996.
  125. A. Senchenkov, D. A. Litvak, and M. C. Cabot, “Targeting ceramide metabolism—a strategy for overcoming drug resistance,” Journal of the National Cancer Institute, vol. 93, no. 5, pp. 347–357, 2001.
  126. Y. Lavie, H. T. Cao, S. L. Bursten, A. E. Giuliano, and M. C. Cabot, “Accumulation of glucosylceramides in multidrug-resistant cancer cells,” Journal of Biological Chemistry, vol. 271, no. 32, pp. 19530–19536, 1996. View at Publisher · View at Google Scholar
  127. A. Lucci, W. I. Cho, T. Y. Han, A. E. Giuliano, D. L. Morton, and M. C. Cabot, “Glucosylceramide: a marker for multiple-drug resistant cancers,” Anticancer Research, vol. 18, no. 1, pp. 475–480, 1998.
  128. H. Morjani, N. Aouali, R. Belhoussine, R. J. Veldman, T. Levade, and M. Manfait, “Elevation of glucosylceramide in multidrug-resistant cancer cells and accumulation in cytoplasmic droplets,” International Journal of Cancer, vol. 94, no. 2, pp. 157–165, 2001. View at Publisher · View at Google Scholar · View at PubMed
  129. R. J. Veldman, K. Klappe, J. Hinrichs, I. Hummel, G. van der Schaaf, H. Sietsma, and J. W. Kok, “Altered sphingolipid metabolism in multidrug-resistant ovarian cancer cells is due to uncoupling of glycolipid biosynthesis in the Golgi apparatus,” The FASEB Journal, vol. 16, no. 9, pp. 1111–1113, 2002.
  130. V. Gouazé-Andersson, J. Y. Yu, A. J. Kreitenberg, A. Bielawska, A. E. Giuliano, and M. C. Cabot, “Ceramide and glucosylceramide upregulate expression of the multidrug resistance gene MDR1 in cancer cells,” Biochimica et Biophysica Acta, vol. 1771, no. 12, pp. 1407–1417, 2007. View at Publisher · View at Google Scholar · View at PubMed
  131. K. Ueda, M. M. Cornwell, M. M. Gottesman, et al., “The mdrl gene, responsible for multidrug-resistance, codes for P-glycoprotein,” Biochemical and Biophysical Research Communications, vol. 141, no. 3, pp. 956–962, 1986.
  132. M. M. Gottesman, I. Pastan, and S. V. Ambudkar, “P-glycoprotein and multidrug resistance,” Current Opinion in Genetics and Development, vol. 6, no. 5, pp. 610–617, 1996. View at Publisher · View at Google Scholar
  133. G. Bradley and V. Ling, “P-glycoprotein, multidrug resistance and tumor progression,” Cancer and Metastasis Reviews, vol. 13, no. 2, pp. 223–233, 1994. View at Publisher · View at Google Scholar
  134. R. J. Veldman, A. Mita, and A. Mita, “The absence of functional glucosylceramide synthase does not sensitize melanoma cells for anticancer drugs,” FASEB Journal, vol. 17, no. 9, pp. 1144–1146, 2003.
  135. N. S. Radin, “Chemotherapy by slowing glucosphingolipid synthesis,” Biochemical Pharmacology, vol. 57, no. 6, pp. 589–595, 1999. View at Publisher · View at Google Scholar
  136. J.-I. Inokuchi, M. Jimbo, K. Momasaki, H. Shimeno, A. Nagamatsu, and N. S. Radin, “Inhibition of experimental metastasis of murine Lewis lung carcinoma by an inhibitor of glycosylceramide synthase and its possible mechanism of action,” Cancer Research, vol. 50, no. 20, pp. 6731–6737, 1990.
  137. C. Mao and L. M. Obeid, “Ceramidases: regulators of cellular responses mediated by ceramide, sphingosine, and sphingosine-1-phosphate,” Biochimica et Biophysica Acta, vol. 1781, no. 9, pp. 424–434, 2008. View at Publisher · View at Google Scholar · View at PubMed
  138. R. S. Seelan, C. Qian, A. Yokomizo, D. G. Bostwick, D. I. Smith, and W. Liu, “Human acid ceramidase is overexpressed but not mutated in prostate cancer,” Genes Chromosomes and Cancer, vol. 29, no. 2, pp. 137–146, 2000. View at Publisher · View at Google Scholar
  139. L. Samsel, G. Zaidel, and G. Zaidel, “The ceramide analog, B13, induces apoptosis in prostate cancer cell lines and inhibits tumor growth in prostate cancer xenografts,” Prostate, vol. 58, no. 4, pp. 382–393, 2004. View at Publisher · View at Google Scholar · View at PubMed
  140. D. H. Holman, L. S. Turner, and L. S. Turner, “Lysosomotropic acid ceramidase inhibitor induces apoptosis in prostate cancer cells,” Cancer Chemotherapy and Pharmacology, vol. 61, no. 2, pp. 231–242, 2008. View at Publisher · View at Google Scholar · View at PubMed
  141. M. Selzner, A. Bielawska, M. A. Morse, H. A. Rüdiger, D. Sindram, Y. A. Hannun, and P. A. Clavien, “Induction of apoptotic cell death and prevention of tumor growth by ceramide analogues in metastatic human colon cancer,” Cancer Research, vol. 61, no. 3, pp. 1233–1240, 2001.
  142. A. F. Rénert, P. Leprince, and P. Leprince, “The proapoptotic C16-ceramide-dependent pathway requires the death-promoting factor Btf in colon adenocarcinoma cells,” Journal of Proteome Research, vol. 8, no. 10, pp. 4810–4822, 2009. View at Publisher · View at Google Scholar · View at PubMed
  143. A. Strelow, K. Bernardo, S. Adam-Klages, T. Linke, K. Sandhoff, M. Krönke, and D. Adam, “Overexpression of acid ceramidase protects from tumor necrosis factor-induced cell death,” Journal of Experimental Medicine, vol. 192, no. 5, pp. 601–611, 2000. View at Publisher · View at Google Scholar
  144. Y. Osawa, H. Uchinami, J. Bielawski, R. F. Schwabe, Y. A. Hannun, and D. A. Brenner, “Roles for C-ceramide and sphingosine 1-phosphate in regulating hepatocyte apoptosis in response to tumor necrosis factor-α,” Journal of Biological Chemistry, vol. 280, no. 30, pp. 27879–27887, 2005. View at Publisher · View at Google Scholar · View at PubMed
  145. R. Xu, J. Jin, and J. Jin, “Golgi alkaline ceramidase regulates cell proliferation and survival by controlling levels of sphingosine and S1P,” FASEB Journal, vol. 20, no. 11, pp. 1813–1825, 2006. View at Publisher · View at Google Scholar · View at PubMed
  146. W. Hu, R. Xu, W. Sun, Z. M. Szulc, J. Bielawski, L. M. Obeid, and C. Mao, “Alkaline ceramidase 3 (ACER3) hydrolyzes unsaturated long-chain ceramides, and its down-regulation inhibits both cell proliferation and apoptosis,” Journal of Biological Chemistry, vol. 285, no. 11, pp. 7964–7976, 2010. View at Publisher · View at Google Scholar · View at PubMed
  147. H. Liu, R. E. Toman, and R. E. Toman, “Sphingosine kinase type 2 is a putative BH3-only protein that induces apoptosis,” Journal of Biological Chemistry, vol. 278, no. 41, pp. 40330–40336, 2003. View at Publisher · View at Google Scholar · View at PubMed
  148. M. Maceyka, H. Sankala, and H. Sankala, “SphK1 and SphK2, sphingosine kinase isoenzymes with opposing functions in sphingolipid metabolism,” Journal of Biological Chemistry, vol. 280, no. 44, pp. 37118–37129, 2005. View at Publisher · View at Google Scholar · View at PubMed
  149. K. J. French, Y. Zhuang, and Y. Zhuang, “Pharmacology and antitumor activity of ABC294640, a selective inhibitor of sphingosine kinase-2,” Journal of Pharmacology and Experimental Therapeutics, vol. 333, no. 1, pp. 129–139, 2010. View at Publisher · View at Google Scholar · View at PubMed
  150. E. Le Scolan, D. Pchejetski, and D. Pchejetski, “Overexpression of sphingosine kinase 1 is an oncogenic event in erythroleukemic progression,” Blood, vol. 106, no. 5, pp. 1808–1816, 2005. View at Publisher · View at Google Scholar · View at PubMed
  151. Q. F. Li, W. R. Huang, H. F. Duan, H. Wang, C. T. Wu, and L. S. Wang, “Sphingosine kinase-1 mediates BCR/ABL-induced upregulation of Mcl-1 in chronic myeloid leukemia cells,” Oncogene, vol. 26, no. 57, pp. 7904–7908, 2007. View at Publisher · View at Google Scholar · View at PubMed
  152. E. Bonhoure, A. Lauret, and A. Lauret, “Sphingosine kinase-1 is a downstream regulator of imatinib-induced apoptosis in chronic myeloid leukemia cells,” Leukemia, vol. 22, no. 5, pp. 971–979, 2008. View at Publisher · View at Google Scholar · View at PubMed
  153. S. Sobue, T. Iwasaki, and T. Iwasaki, “Quantitative RT-PCR analysis of sphingolipid metabolic enzymes in acute leukemia and myelodysplastic syndromes,” Leukemia, vol. 20, no. 11, pp. 2042–2046, 2006. View at Publisher · View at Google Scholar · View at PubMed
  154. B. S. Paugh, S. W. Paugh, and S. W. Paugh, “EGF regulates plasminogen activator inhibitor-1 (PAI-1) by a pathway involving c-Src, PKCδ, and sphingosine kinase 1 in glioblastoma cells,” FASEB Journal, vol. 22, no. 2, pp. 455–465, 2008. View at Publisher · View at Google Scholar · View at PubMed
  155. P. Xia, J. R. Gamble, and J. R. Gamble, “An oncogenic role of sphingosine kinase,” Current Biology, vol. 10, no. 23, pp. 1527–1530, 2000. View at Publisher · View at Google Scholar
  156. X. Shu, W. Wu, R. D. Mosteller, and D. Broek, “Sphingosine kinase mediates vascular endothelial growth factor-induced activation of ras and mitogen-activated protein kinases,” Molecular and Cellular Biology, vol. 22, no. 22, pp. 7758–7768, 2002. View at Publisher · View at Google Scholar
  157. K. J. French, R. S. Schrecengost, and R. S. Schrecengost, “Discovery and evaluation of inhibitors of human sphingosine kinase,” Cancer Research, vol. 63, no. 18, pp. 5962–5969, 2003.
  158. K. R. Johnson, K. Y. Johnson, H. G. Crellin, B. Ogretmen, A. M. Boylan, R. A. Harley, and L. M. Obeid, “Immunohistochemical distribution of sphinqosine kinase 1 in normal and tumor lung tissue,” Journal of Histochemistry and Cytochemistry, vol. 53, no. 9, pp. 1159–1166, 2005. View at Publisher · View at Google Scholar · View at PubMed
  159. M. Kohno, M. Momoi, and M. Momoi, “Intracellular role for sphingosine kinase 1 in intestinal adenoma cell proliferation,” Molecular and Cellular Biology, vol. 26, no. 19, pp. 7211–7223, 2006. View at Publisher · View at Google Scholar · View at PubMed
  160. S. E. Schnitzer, A. Weigert, J. Zhou, and B. Brüne, “Hypoxia enhances sphingosine kinase 2 activity and provokes sphingosine-1-phosphate-mediated chemoresistance in A549 lung cancer cells,” Molecular Cancer Research, vol. 7, no. 3, pp. 393–401, 2009. View at Publisher · View at Google Scholar · View at PubMed
  161. Y. Zhang, P. Mattjus, and P. Mattjus, “Involvement of the acid sphingomyelinase pathway in UVA-induced apoptosis,” Journal of Biological Chemistry, vol. 276, no. 15, pp. 11775–11782, 2001. View at Publisher · View at Google Scholar · View at PubMed
  162. P. Santana, L. A. Peña, and L. A. Peña, “Acid sphingomyelinase-deficient human lymphoblasts and mice are defective in radiation-induced apoptosis,” Cell, vol. 86, no. 2, pp. 189–199, 1996. View at Publisher · View at Google Scholar
  163. A. Carpinteiro, C. Dumitru, M. Schenck, and E. Gulbins, “Ceramide-induced cell death in malignant cells,” Cancer Letters, vol. 264, no. 1, pp. 1–10, 2008. View at Publisher · View at Google Scholar · View at PubMed
  164. E. L. Smith and E. H. Schuchman, “The unexpected role of acid sphingomyelinase in cell death and the pathophysiology of common diseases,” FASEB Journal, vol. 22, no. 10, pp. 3419–3431, 2008. View at Publisher · View at Google Scholar · View at PubMed
  165. B. Stancevic and R. Kolesnick, “Ceramide-rich platforms in transmembrane signaling,” FEBS Letters, vol. 584, no. 9, pp. 1728–1740, 2010. View at Publisher · View at Google Scholar · View at PubMed
  166. J. A. Rotolo, J. Zhang, M. Donepudi, H. Lee, Z. Fuks, and R. Kolesnick, “Caspase-dependent and -independent activation of acid sphingomyelinase signaling,” Journal of Biological Chemistry, vol. 280, no. 28, pp. 26425–26434, 2005. View at Publisher · View at Google Scholar · View at PubMed
  167. X. Liang and Y. Huang, “Physical state changes of membrane lipids in human lung adenocarcinoma A549 cells and their resistance to cisplatin,” International Journal of Biochemistry and Cell Biology, vol. 34, no. 10, pp. 1248–1255, 2002. View at Publisher · View at Google Scholar
  168. O. Cuvillier and T. Levade, “Sphingosine 1-phosphate antagonizes apoptosis of human leukemia cells by inhibiting release of cytochrome c and Smac/DIABLO from mitochondria,” Blood, vol. 98, no. 9, pp. 2828–2836, 2001. View at Publisher · View at Google Scholar
  169. B. Oskouian, P. Soonyakumaran, and P. Soonyakumaran, “Sphingosine-1-phosphate lyase potentiates apoptosis via p53- and p38-dependent pathways and is down-regulated in colon cancer,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 46, pp. 17384–17389, 2006. View at Publisher · View at Google Scholar · View at PubMed
  170. U. Reiss, B. Oskouian, and B. Oskouian, “Sphingosine-phosphate lyase enhances stress-induced ceramide generation and apoptosis,” Journal of Biological Chemistry, vol. 279, no. 2, pp. 1281–1290, 2004. View at Publisher · View at Google Scholar · View at PubMed
  171. A. Charruyer, S. M. Bell, and S. M. Bell, “Decreased ceramide transport protein (CERT) function alters sphingomyelin production following UVB irradiation,” Journal of Biological Chemistry, vol. 283, no. 24, pp. 16682–16692, 2008. View at Publisher · View at Google Scholar · View at PubMed
  172. T. Watanabe, H. Tsuge, T. Oh-Hara, M. Naito, and T. Tsuruo, “Comparative study on reversal efficacy of SDZ PSC 833, cyclosporin A and verapamil on multidrug resistance in vitro and in vivo,” Acta Oncologica, vol. 34, no. 2, pp. 235–241, 1995.
  173. Y. Lavie, H. T. Cao, and H. T. Cao, “Agents that reverse multidrug resistance, tamoxifen, verapamil, and cyclosporin A, block glycosphingolipid metabolism by inhibiting ceramide glycosylation in human cancer cells,” Journal of Biological Chemistry, vol. 272, no. 3, pp. 1682–1687, 1997. View at Publisher · View at Google Scholar
  174. A. Lucci, T. Y. Han, Y. Y. Liu, A. E. Giuliano, and M. C. Cabot, “Multidrug resistance modulators and doxorubicin synergize to elevate ceramide levels and elicit apoptosis in drug-resistant cancer cells,” Cancer, vol. 86, no. 2, pp. 300–311, 1999. View at Publisher · View at Google Scholar
  175. M. C. Cabot, T. Y. Han, and A. E. Giuliano, “The multidrug resistance modulator SDZ PSC 833 is a potent activator of cellular ceramide formation,” FEBS Letters, vol. 431, no. 2, pp. 185–188, 1998. View at Publisher · View at Google Scholar
  176. N. Aouali, L. Eddabra, J. Macadré, and H. Morjani, “Immunosuppressors and reversion of multidrug-resistance,” Critical Reviews in Oncology/Hematology, vol. 56, no. 1, pp. 61–70, 2005. View at Publisher · View at Google Scholar · View at PubMed
  177. B. J. Maurer, L. Melton, C. Billups, M. C. Cabot, and C. P. Reynolds, “Synergistic cytotoxicity in solid tumor cell lines between N-(4-hydroxyphenyl)retinamide and modulators of ceramide metabolism,” Journal of the National Cancer Institute, vol. 92, no. 23, pp. 1897–1909, 2000.
  178. D. B. Jendiroba, J. Klostergaard, A. Keyhani, L. Pagliaro, and E. J. Freireich, “Effective cytotoxicity against human leukemias and chemotherapy-resistant leukemia cell lines by N-N-dimethylsphingosine,” Leukemia Research, vol. 26, no. 3, pp. 301–310, 2002. View at Publisher · View at Google Scholar
  179. S. Sarkar, M. Maceyka, N. C. Hait, S. W. Paugh, H. Sankala, S. Milstien, and S. Spiegel, “Sphingosine kinase 1 is required for migration, proliferation and survival of MCF-7 human breast cancer cells,” FEBS Letters, vol. 579, no. 24, pp. 5313–5317, 2005. View at Publisher · View at Google Scholar · View at PubMed
  180. H. M. Sankala, N. C. Hait, and N. C. Hait, “Involvement of sphingosine kinase 2 in p53-independent induction of p21 by the chemotherapeutic drug doxorubicin,” Cancer Research, vol. 67, no. 21, pp. 10466–10474, 2007. View at Publisher · View at Google Scholar · View at PubMed
  181. T. Shirahama, E. A. Sweeney, and E. A. Sweeney, “In vitro and in vivo induction of apoptosis by sphingosine and N,N-dimethylsphingosine in human epidermoid carcinoma KB-3-1 and its multidrug-resistant cells,” Clinical Cancer Research, vol. 3, no. 2, pp. 257–264, 1997.
  182. Z. Mao, W. Sun, and W. Sun, “Alkaline ceramidase 2 (ACER2) and its product dihydrosphingosine mediate the cytotoxicity of N-(4-Hydroxyphenyl)retinamide in tumor cells,” Journal of Biological Chemistry, vol. 285, no. 38, pp. 29078–29090, 2010. View at Publisher · View at Google Scholar · View at PubMed
  183. C. Ji, B. Yang, Y.-L. Yang, S.-H. He, D.-S. Miao, L. He, and Z.-G. Bi, “Exogenous cell-permeable C6 ceramide sensitizes multiple cancer cell lines to Doxorubicin-induced apoptosis by promoting AMPK activation and mTORC1 inhibition,” Oncogene. In press. View at Publisher · View at Google Scholar · View at PubMed
  184. A. P. Bruno, G. Laurent, and G. Laurent, “Lack of ceramide generation in TF-1 human myeloid leukemic cells resistant to ionizing radiation,” Cell Death and Differentiation, vol. 5, no. 2, pp. 172–182, 1998. View at Scopus
  185. J. M. Michael, M. F. Lavin, and D. J. Watters, “Resistance to radiation-induced apoptosis in Burkitt's lymphoma cells is associated with defective ceramide signaling,” Cancer Research, vol. 57, no. 16, pp. 3600–3605, 1997. View at Scopus
  186. C. P. Thomas, A. Buronfosse, V. Combaret, S. Pedron, B. Fertil, and J. Portoukalian, “Gangliosides protect human melanoma cells from ionizing radiation-induced clonogenic cell death,” Glycoconjugate Journal, vol. 13, no. 3, pp. 377–384, 1996. View at Publisher · View at Google Scholar · View at Scopus
  187. S. Hara, S. Nakashima, and S. Nakashima, “p53-independent ceramide formation in human glioma cells during γ-radiation-induced apoptosis,” Cell Death and Differentiation, vol. 11, no. 8, pp. 853–861, 2004. View at Publisher · View at Google Scholar · View at PubMed
  188. S. Hara, S. Nakashima, T. Kiyono, M. Sawada, S. I. Yoshimura, T. Iwama, and N. Sakai, “Ceramide triggers caspase activation during gamma-radiation-induced apoptosis of human glioma cells lacking functional p53,” Oncology Reports, vol. 12, no. 1, pp. 119–123, 2004. View at Scopus
  189. C. L. Sawyers, A. Hochhaus, and A. Hochhaus, “Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study,” Blood, vol. 99, no. 10, pp. 3530–3539, 2002. View at Publisher · View at Google Scholar
  190. Y. Baran, A. Salas, C. E. Senkal, U. Gunduz, J. Bielawski, L. M. Obeid, and B. Ogretmen, “Alterations of ceramide/sphingosine 1-phosphate rheostat involved in the regulation of resistance to imatinib-induced apoptosis in K562 human chronic myeloid leukemia cells,” Journal of Biological Chemistry, vol. 282, no. 15, pp. 10922–10934, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  191. S. M. Wilhelm, C. Carter, and C. Carter, “BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis,” Cancer Research, vol. 64, no. 19, pp. 7099–7109, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  192. V. Beljanski, C. Knaak, Y. Zhuang, and C. D. Smith, “Combined anticancer effects of sphingosine kinase inhibitors and sorafenib,” Investigational New Drugs. In press. View at Publisher · View at Google Scholar · View at PubMed
  193. J. S. Norris, A. Bielawska, and A. Bielawska, “Combined therapeutic use of AdGFPFasL and small molecule inhibitors of ceramide metabolism in prostate and head and neck cancers: a status report,” Cancer Gene Therapy, vol. 13, no. 12, pp. 1045–1051, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  194. R. C. Kane, A. T. Farrell, and A. T. Farrell, “Sorafenib for the treatment of advanced renal cell carcinoma,” Clinical Cancer Research, vol. 12, no. 24, pp. 7271–7278, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  195. M. A. Tran, C. D. Smith, M. Kester, and G. P. Robertson, “Combining nanoliposomal ceramide with sorafenib synergistically inhibits melanoma and breast cancer cell survival to decrease tumor development,” Clinical Cancer Research, vol. 14, no. 11, pp. 3571–3581, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus